InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,952.00
(
-0.19%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.62
(
0.09%
)
Bitcoin
57,802.87
(
-0.74%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 237104

Wednesday, 08/09/2023 10:09:07 AM

Wednesday, August 09, 2023 10:09:07 AM

Post# of 251670
REGN acquires DBTX for $4.00/sh cash +CVR; the cash portion of the deal is a 43% premium to yesterday’s close, but a 78% discount to DBTX’s 2021 IPO (#msg-161773246):

https://finance.yahoo.com/news/regeneron-acquire-decibel-therapeutics-strengthening-113000878.html

Regeneron Pharmaceuticals and Decibel Therapeutics…today announced a definitive agreement for the acquisition of Decibel by Regeneron at a price of $4.00 per share of Decibel common stock payable in cash at closing, with an additional non-tradeable contingent value right (CVR) to receive up to $3.50 per share in cash upon achievement of certain clinical development and regulatory milestones for Decibel’s lead investigational candidate, DB-OTO, within specified time periods.

The nominal deal value (excluding the CVR) is $109M.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up